Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$25.38 - $34.89 $5.08 Million - $6.98 Million
-200,000 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$17.75 - $27.58 $3.55 Million - $5.52 Million
200,000 New
200,000 $5.52 Million
Q1 2019

May 10, 2019

SELL
$11.34 - $20.62 $5.96 Million - $10.8 Million
-525,805 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$12.32 - $24.38 $2.46 Million - $4.88 Million
200,000 Added 61.39%
525,805 $7.34 Million
Q3 2018

Nov 13, 2018

SELL
$18.82 - $28.96 $5.06 Million - $7.79 Million
-268,859 Reduced 45.21%
325,805 $7.8 Million
Q2 2018

Aug 14, 2018

BUY
$8.79 - $19.98 $5.23 Million - $11.9 Million
594,664 New
594,664 $11.2 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.